Previous Close | 63.22 |
Open | 62.79 |
Bid | 63.41 x 200 |
Ask | 63.49 x 200 |
Day's Range | 61.78 - 64.91 |
52 Week Range | 56.05 - 100.77 |
Volume | |
Avg. Volume | 2,420,254 |
Market Cap | 11.524B |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.13 |
Earnings Date | May 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 90.66 |
Exact Sciences (EXAS) concluded the recent trading session at $63.22, signifying a -1% move from its prior day's close.
With the business potentially at an important milestone, we thought we'd take a closer look at Exact Sciences...
MADISON, Wis., April 15, 2024--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024.